 SOUTH SAN FRANCISCO, Calif., April 27, 2022 GLOBE NEWSWIRE -- CareDx, Inc. Nasdaq: CDNA The Transplant CompanyTM focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients today announced it will report financial results for the first quarter 2022 after market close on Thursday, May 5, 2022. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time 4:30 p.m. Eastern Time. 